000 | 01194 a2200325 4500 | ||
---|---|---|---|
005 | 20250513093256.0 | ||
264 | 0 | _c19960911 | |
008 | 199609s 0 0 eng d | ||
022 | _a0271-0749 | ||
024 | 7 |
_a10.1097/00004714-199604001-00003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKeck, P E | |
245 | 0 | 0 |
_aOutcome in the pharmacologic treatment of bipolar disorder. _h[electronic resource] |
260 |
_bJournal of clinical psychopharmacology _cApr 1996 |
||
300 |
_a15S-23S p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntimanic Agents _xadverse effects |
650 | 0 | 4 |
_aBipolar Disorder _xdiagnosis |
650 | 0 | 4 |
_aCarbamazepine _xadverse effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLithium _xadverse effects |
650 | 0 | 4 |
_aPsychotropic Drugs _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aValproic Acid _xadverse effects |
700 | 1 | _aMcElroy, S L | |
773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 16 _gno. 2 Suppl 1 _gp. 15S-23S |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004714-199604001-00003 _zAvailable from publisher's website |
999 |
_c8705238 _d8705238 |